Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden In Symptomatic And Asymptomatic Patients Following RF Ablation
Links shared publicly online about this topic.
- 313total visits
Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden In Symptomatic And Asymptomatic Patients Following RF Ablation
Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal® XT insertable cardiac monitor to conduct long-term monitoring to assess the i
View full resource at medicalnewstoday.com
Tags: Heart
Most Recently Shared on May 6, 2011 at 10:38 am By:
Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden In Symptomatic And Asym... http://bit.ly/l4xz24 #MedDevice
Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF Burden In Symptomatic And Asymptomatic Patients Following RF Ablation
medicalnewstoday.com — “Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal® XT insertable cardiac monitor to conduct long-term monitoring to assess the i” View full resource at medicalnewstoday.com
Most Recently Shared on May 6, 2011 at 10:05 am By:
MedicalNewsToday: Medtronic's Reveal(R) XT Insertable Cardiac Monitor Helps Determine AF: http://bit.ly/mwsz8K Full http://bit.ly/iP3oWG
Advertisement
